NAN · ASX

Nanosonics Limited (ASX:NAN)

AU$4.46

 -0.39 (-8.041%)
ASX:Live
17/04/2025 04:10:20 PM
HALO Small HALO Ords HALO Momentum HALO Earnings Momentum HALO Balance Sheet +5
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

NAN Overview

NAN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Very Strong

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Neutral

Balance Sheet

Very Weak

About NAN

Website

Nanosonics Limited

Telephone

61.2.8063.1600

Address

Building A, Level 1 7-11 Talavera Road Macquarie Park Sydney, New South Wales (NSW) 2113

Description

Nanosonics Ltd. engages in the provision of research, development, and commercialization of infection control and decontamination products and related technologies. It operates through the following geographical segments: North America, Europe and Middle East, and Asia Pacific. Its products include trophon EPR, trophon technology, and trophon2. The company was founded by Maurie Stang on November 14, 2000 and is headquartered in Sydney, Australia.

NAN Price Chart

Key Stats

Market Cap

AU$1.47B

PE

78.20

EV/EBITDA

48.0

Dividends Overview

DIV Yield

.0%

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.64 - 5.18

Trade Value (12mth)

AU$790,338.00

1 week

-3.67%

1 month

1.36%

YTD

48.17%

1 year

60.43%

All time high

8.25

Key Fundamentals

EPS 3 yr Growth

50.20%

EBITDA Margin

9.30%

Operating Cashflow

$23m

Free Cash Flow Return

12.70%

ROIC

7.20%

Interest Coverage

14.50

Quick Ratio

5.50

Other Data

Shares on Issue (Fully Dilluted)

309m

HALO Sector

Healthcare

Next Company Report Date

01-Sep-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

3.78

NAN Announcements

Latest Announcements

Date Announcements

31 March 25

Notification of cessation of securities - NAN

×

Notification of cessation of securities - NAN

25 March 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

25 March 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

24 March 25

Application for quotation of securities - NAN

×

Application for quotation of securities - NAN

20 March 25

Nanosonics Receives FDA De Novo Clearance for CORIS

×

Nanosonics Receives FDA De Novo Clearance for CORIS

14 March 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

13 March 25

Application for quotation of securities - NAN

×

Application for quotation of securities - NAN

12 March 25

Update - Notification regarding unquoted securities - NAN

×

Update - Notification regarding unquoted securities - NAN

12 March 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

11 March 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

06 March 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

20 February 25

Appendix 4D and Half Year Accounts

×

Appendix 4D and Half Year Accounts

20 February 25

2025 Half Year Financial Results Investor Presentation

×

2025 Half Year Financial Results Investor Presentation

20 February 25

2025 Half Year Financial Results

×

2025 Half Year Financial Results

28 January 25

Ceasing to be a substantial holder from MUFG

×

Ceasing to be a substantial holder from MUFG

28 January 25

Change in substantial holding

×

Change in substantial holding

24 January 25

2025 Half Year Results conference call notification

×

2025 Half Year Results conference call notification

23 January 25

H1 FY25 trading update

×

H1 FY25 trading update

14 January 25

Appointment of Non-Executive Director and Appendix 3X

×

Appointment of Non-Executive Director and Appendix 3X

20 December 24

Notification regarding unquoted securities - NAN

×

Notification regarding unquoted securities - NAN

20 December 24

Change in substantial holding from MUFG

×

Change in substantial holding from MUFG

19 December 24

Change in substantial holding

×

Change in substantial holding

10 December 24

Notification regarding unquoted securities - NAN

×

Notification regarding unquoted securities - NAN

10 December 24

Application for quotation of securities - NAN

×

Application for quotation of securities - NAN

10 December 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

NAN Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 0.07 0.04 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 0.06 0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -56.5 432.3 -35.2 Lock Lock Lock
     PE X Lock Lock Lock Lock 1,547.4 87.9 78.2 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 249.8 55.5 48.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.02 0.10 0.06 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 0.06 0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -62.7 336.6 -33.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock -0.0 1.4 2.2 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.46 0.54 0.60 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.46 0.54 0.60 Lock Lock Lock
     Growth % Lock Lock Lock Lock 2.2 18.1 11.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 306 306 309 Lock Lock Lock
Basic m Lock Lock Lock Lock 301 301 303 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 120 168 172 Lock Lock Lock
     Growth % Lock Lock Lock Lock 17.6 39.9 2.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 85 108 119 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 86 126 127 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.0 45.9 1.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock 72.0 75.0 74.1 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 28 25 26 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 7 25 16 Lock Lock Lock
     Growth % Lock Lock Lock Lock -49.1 285.6 -36.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock 5.4 15.0 9.3 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 6 7 8 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 1 18 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -90.5 2,172.6 -53.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.7 10.7 4.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 2 22 13 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 2 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 4 20 13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -56.4 431.3 -34.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock 3.1 11.9 7.6 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 7 23 23 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 7 4 3 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -7 -4 -2 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 0 20 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock -101.5 21,565.2 2.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.0 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 95 112 130 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 193 226 242 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 9 8 6 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -83 -101 -120 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 55 62 60 Lock Lock Lock
Equity $m Lock Lock Lock Lock 139 164 182 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 148 172 188 Lock Lock Lock
     Growth % Lock Lock Lock Lock 8.3 16.1 9.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 1.9 8.8 5.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 2.7 12.1 7.1 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 0.5 11.1 4.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 2.6 12.4 7.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 4.7 14.6 12.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock 11.7 32.6 14.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -12.7 -4.0 -7.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -59.7 -61.9 -66.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.3 5.5 6.1 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 4.5 4.7 5.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 62.8 61.9 65.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 23.4 70.6 70.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.3 5.0 4.3 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 1.9 1.7 1.9 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.0 1.1 1.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 2.3 2.2 2.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.6 0.7 0.7 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.6 0.7 0.7 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 1.3 12.9 7.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.8 9.6 5.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock -137.1 7.9 0.1 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 1.9 8.8 5.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.4 1.4 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 2.7 12.1 7.1 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 2.7 12.1 7.1 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 187.4 209.7 188.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 85.8 73.2 84.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 273.2 283.0 272.4 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 26.1 26.5 33.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 247.2 256.4 238.7 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

.0%

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

3.78%

Value ($M)

53

Prior Change

N/A

7 Day Change

-0.40%

1 Month Change

-0.30%

3 Month Change

-0.40%

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

NAN Shortsell

Frequently Asked Questions

The current share price of Nanosonics Limited (NAN:ASX) is AU$4.46.
The 52-week high share price for Nanosonics Limited (NAN:ASX) is AU$5.18.
The 52-week low share price for Nanosonics Limited (NAN:ASX)? is AU$2.64.
The current TTM dividend payout for Nanosonics Limited (NAN:ASX) is 0.00.
Nanosonics Limited (NAN:ASX) does not pay a dividend.
Nanosonics Limited (NAN:ASX) has a franking level of 0.0%.
Nanosonics Limited (NAN:ASX) is classified in the Healthcare.
The current P/E ratio for Nanosonics Limited (NAN:ASX) is 78.20.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.